Jamal Rana, MD (@jamalranamd) 's Twitter Profile
Jamal Rana, MD

@jamalranamd

Cardiologist & Researcher @PermanenteDocs| Chair Med Specialties & Interventional Services| Past President @CaliforniaACC| @CedarsSinai Alum| Opinions own

ID: 1379288939140325381

linkhttps://pubmed.ncbi.nlm.nih.gov/?term=Rana+js&sort=date calendar_today06-04-2021 04:25:05

7,7K Tweet

4,4K Followers

673 Following

EAS Congress (@eascongress) 's Twitter Profile Photo

What happens when science meets storytelling? At the EAS Stage, the SoMe Team explored how social media can amplify research, boost physician voices & spark real-time connections. 👉Social media isn’t just a tool — it’s part of the conversation.#EASCongress2025

What happens when science meets storytelling?

At the EAS Stage, the SoMe Team explored how social media can amplify research, boost physician voices & spark real-time connections.

👉Social media isn’t just a tool — it’s part of the conversation.#EASCongress2025
NewAmsterdam Pharma Corporation (@newamspharma) 's Twitter Profile Photo

1 in 4 U.S. adults—over 63 million people—have high LDL-C, a key driver of cardiovascular disease. Managing cholesterol isn’t just about numbers—it’s about taking action to reduce your risk of a cardiovascular event.

Pradeep Natarajan (@pnatarajanmd) 's Twitter Profile Photo

Among N=2530 w HeFH or ASCVD on max tolerated LLT with insufficiently low LDL-C (mean 98mg/dl), obicetrapib (CETPi) 10mg po daily v placebo led to 33% lower LDL-C at 3mo nejm.org/doi/full/10.10… NEJM NewAmsterdam Pharma Corporation #EAS2025 [1/5]

Among N=2530 w HeFH or ASCVD on max tolerated LLT with insufficiently low LDL-C (mean 98mg/dl), obicetrapib (CETPi) 10mg po daily v placebo led to 33% lower LDL-C at 3mo nejm.org/doi/full/10.10… <a href="/NEJM/">NEJM</a> <a href="/NewAmsPharma/">NewAmsterdam Pharma Corporation</a> #EAS2025 

[1/5]
Niharika Reddy, MD (@niharika_reddy9) 's Twitter Profile Photo

Grateful for the chance to speak at #EASCongress2025 about how social media shapes scientific careers and build global networks. Reflecting on how these platforms amplified my journey in science was a full-circle moment. Thank you, EAS, for having me—see you in Greece next year!

Grateful for the chance to speak at #EASCongress2025 about how social media shapes scientific careers and build global networks. Reflecting on how these platforms amplified my journey in science was a full-circle moment. Thank you, EAS, for having me—see you in Greece next year!
Jamal Rana, MD (@jamalranamd) 's Twitter Profile Photo

Göran Hansson VC of BOD Nobel Foundation #EASCongress2025. "... most worthy individual shall receive prize irrespective Scandinavian or not." ⚡We award #discoveries, not lifetime achievement, not H-index or impact factor ⚡Discovery should change field & lead to great benefit

Göran Hansson VC of BOD Nobel Foundation #EASCongress2025. "... most worthy individual shall receive prize irrespective Scandinavian or not." 
⚡We award #discoveries, not lifetime achievement, not H-index or impact factor 
 ⚡Discovery should change field &amp; lead to great benefit
Jamal Rana, MD (@jamalranamd) 's Twitter Profile Photo

Ultra-Processed Foods May Be Associated With Adverse Health Outcomes - American College of Cardiology acc.org/latest-in-card…

Henry Han (@hancardiomd) 's Twitter Profile Photo

#Spironolactone vs #Amiloride for Resistant Hypertension A Randomized Clinical Trial N = 118 (1:1 randomization) 📍 12-week home #SBP ↓:  • Amiloride: −13.6 mm Hg  • Spironolactone: −14.7 mm Hg 📍 Between-group difference: −0.68 mm Hg (90% CI −3.50 to 2.14) ✅

#Spironolactone vs #Amiloride for Resistant Hypertension
A Randomized Clinical Trial

N = 118 (1:1 randomization)
📍 12-week home #SBP ↓: 
 • Amiloride: −13.6 mm Hg
 • Spironolactone: −14.7 mm Hg
📍 Between-group difference: −0.68 mm Hg (90% CI −3.50 to 2.14)
✅
Srihari S. Naidu, MD (@sriharinaidumd) 's Twitter Profile Photo

I don’t control what SCAI posts after internal deliberation. Best to leave a firewall there. So I’m particularly happy they chose to post this episode. I take on some tough topics. Take a listen if you haven’t already. Ankur Kalra Dr. Purvi Parwani Jamal Rana, MD Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦

JOHN GORDON HAROLD, MD, MACC, MACP, FRCP, FRCPI (@jgharoldmd) 's Twitter Profile Photo

Primacy of primary care in combating CVD #WORLDHEARTSUMMIT World Heart Federation Plenary Speaker: Dr. Tom Frieden -President and CEO - Resolve To Save Lives-collaborates locally and globally to build solutions that save millions of lives World Health Organization (WHO) -HEARTS HBP Rx JOHN GORDON HAROLD, MD, MACC, MACP, FRCP, FRCPI American College of Cardiology

Primacy of primary care in combating CVD
#WORLDHEARTSUMMIT <a href="/worldheartfed/">World Heart Federation</a> Plenary Speaker: Dr. Tom Frieden -President and CEO - Resolve To Save Lives-collaborates locally and globally to build solutions that save millions of lives
 <a href="/WHO/">World Health Organization (WHO)</a> -HEARTS HBP Rx
 <a href="/jgharoldmd/">JOHN GORDON HAROLD, MD, MACC, MACP, FRCP, FRCPI</a>
<a href="/ACCinTouch/">American College of Cardiology</a>
JAMA Cardiology (@jamacardio) 's Twitter Profile Photo

Most viewed this week from JAMA Cardiology: Long-term QOL and chest pain outcomes were the same with computed tomography- vs invasive coronary angiography-guided first-test strategies at 3.5 years. ja.ma/4mknrlW

Most viewed this week from <a href="/JAMACardio/">JAMA Cardiology</a>:

Long-term QOL and chest pain outcomes were the same with computed tomography- vs invasive coronary angiography-guided first-test strategies at 3.5 years. 

ja.ma/4mknrlW